Genpact

Genpact reported adjusted EPS of $1.00 for Q2 2026 (expectation $0.96) and revenue of $1.343 billion, up 7.1% year over year. The driver was the Advanced Technology Solutions (ATS) segment, which grew 24.1% and now accounts for 27% of revenue. Gross margin rose for the 13th consecutive quarter to 36.5%, and adjusted operating margin was 17.4%. The company raised its full-year ATS growth outlook to at least 25%, confirmed overall revenue growth of at least 7% for the year, and provided Q3 guidance and an adjusted EPS target of $1.04–$1.05. » Más en de.investing.com

Genpact has unveiled the Banking Analyst Suite; the first module, Transaction Monitoring Analyst, uses AI agents to support investigations of suspected money‑laundering reports, assess customer behavior, analyze transactions and review prior reports. Final decisions remain with a human analyst, and the system requires approval before any regulatorily relevant actions. Genpact expects investigations to be up to 80% faster and operating costs up to 40% lower, but notes dependence on customer data and implementation. AMP Limited is among the first users; the suite is planned to be extended to other regulated banking processes. » Más en de.investing.com

Genpact and Nestle Business Solutions are establishing a Global Capability Center in Hyderabad to transform business processes using AI and automation. Genpact will provide process intelligence, technological capabilities and support the center’s operations, which aim to improve digital transformation, operational transparency and consistency across Nestle’s global network. The location was chosen because of Hyderabad’s technology ecosystem. » Más en de.investing.com

Genpact reported Q1 EPS of $0.98 (expectation $0.92) and revenue of $1.3 billion, driven by 24% growth in the Advanced Technology Solutions segment, which now represents 27% of revenue. Gross margin and adjusted operating income improved; the company is shifting more toward non‑FTE‑based revenue models. Despite the positive results, the stock fell 3.67% in after‑hours trading; Genpact reconfirmed EPS guidance of $1.00 for Q3 and $4.10 for fiscal 2026. » Más en de.investing.com

Genpact shares hit a 52-week low of $33.12 after losing about 30% over the past year. Despite the price pressure the stock trades at a P/E of 10.88 and is rated undervalued by InvestingPro. Genpact recently beat fourth-quarter revenue and earnings expectations, drove growth in its Advanced Technology Solutions segment and announced a quarterly dividend of $0.1875. Analysts adjusted price targets (BMO $44, Needham $50), and the board plans a partnership with Parallel Web Systems to integrate AI-native web‑research tools. » Más en de.investing.com